LENZ Therapeutics, Inc. (LENZ)
$4.59-1.92%Close
SELLCRISIS · day 8
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $144M
- Avg volume
- 872.1K
- Beta
- 1.63
- P/E (TTM)
- -1.12
- Short % float
- 41.38%
- Days to cover
- 11.8
- SI change
- -4.6%
- 1W
- -4.18%
- 1M
- -16.24%
- 3M
- -39.21%
- YTD
- -71.31%
- vs SPY 1W
- -2.98%
- vs SPY 1M
- -19.56%
- vs SPY 3M
- -41.60%
- vs SPY YTD
- -83.07%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- AGIOSELLAgios Pharmaceuticals, Inc.RECOVERYQ 4$32.64-1.36%
- SOPHBUYSOPHiA GENETICS S.A.BULLQ 2$8.45-2.31%
- URGNBUYUroGen Pharma Ltd.BULLQ 23$46.16-1.49%
- OGENBUYOragenics, Inc.RECOVERYQ -10$0.52-1.89%
- PIIISELLP3 Health Partners Inc.CRISISQ -13$10.03-2.72%
- ADAPYSELLAdaptimmune Therapeutics plcCRISISQ -4$0.03+0.00%
- PAVSBUYParanovus Entertainment Technology Ltd.CRISISQ -40$5.15+2.39%
- SYBXBUYSynlogic, Inc.RECOVERYQ -21$1.18-1.67%
- NSRXBUYNasus Pharma Ltd.RECOVERYQ -25$4.07+1.75%
- CLSDSELLClearside Biomedical, Inc.CRISISQ -15$0.25+0.00%
- LUCYBUYInnovative Eyewear, Inc.RECOVERYQ -17$1.12+64.71%
- MENSSELLJyong Biotech Ltd. Ordinary SharesRECOVERYQ -30$2.22+1.83%
Industry peers
FMP comparable companies · ranked by market cap
- NBTXBUYNanobiotix S.A.$2.3BCRISISQ 23$45.39-8.93%
- GHRSBUYGH Research PLC$2.0BBEARQ 19$29.80-0.81%
- MRVIBUYMaravai LifeSciences Holdings, Inc.$2.0BBULLQ -1$7.22-2.43%
- TYRASELLTyra Biosciences, Inc.$1.6BCRISISQ 9$26.81+0.15%
- SVRASELLSavara Inc.$1.1BRECOVERYQ 12$5.58-0.54%
- GERNBUYGeron Corporation$1.0BRECOVERYQ 11$1.59+0.00%
- ABUSBUYArbutus Biopharma Corp$984MRECOVERYQ 13$4.98-0.19%
- PRMESELLPrime Medicine, Inc.$639MRECOVERYQ -9$3.54-4.13%
- SPRYBUYARS Pharmaceuticals, Inc.$634MCRISISQ -2$6.38-2.90%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 11
- VALUE
- 6
- GROWTH
- 37
- GARP
- 4
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-32.0%
REV YoY-
ROE-53.4%
EPS YoY-
ROA-53.3%
GROSS90
OP-632
NET-587
[VALUATION]
P/E TTM-1.12
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B0.66
P/FCF-
EV/EBITDA-0.95
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E0.06
ALTMAN Z-
CURR RATIO13.55
ND/EBITDA-
BETA1.63
